Extranodal marginal zone b-cell lymphoma (malt type) and Weakness

Summary:

Weakness is found among people with Extranodal marginal zone b-cell lymphoma (malt type), especially for people who are female, 60+ old.

The study analyzes which people have Weakness with Extranodal marginal zone b-cell lymphoma (malt type). It is created by eHealthMe based on reports of 17 people who have Extranodal marginal zone b-cell lymphoma (malt type) from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Extranodal marginal zone b-cell lymphoma (malt type)?

Extranodal marginal zone b-cell lymphoma (malt type) (cancer originating from b cells in the marginal zone of the malt) is found to be associated with 41 drugs and 211 conditions by eHealthMe. Check the latest studies of Extranodal marginal zone b-cell lymphoma (malt type).

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

17 people who have Extranodal Marginal Zone B-Cell Lymphoma (Malt Type) and Weakness are studied.

Would you have Weakness when you have Extranodal marginal zone b-cell lymphoma (malt type)?

Gender of people who have Extranodal Marginal Zone B-Cell Lymphoma (Malt Type) and experienced Weakness *:

female: 61.54 %
male: 38.46 %

Age of people who have Extranodal Marginal Zone B-Cell Lymphoma (Malt Type) and experienced Weakness *:

Common co-existing conditions for these people *:

Otitis (ear infection): 2 people, 11.76%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 11.76%
Stress And Anxiety: 1 person, 5.88%
Rashes (redness): 1 person, 5.88%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.88%
Itching: 1 person, 5.88%
Herpes Zoster: 1 person, 5.88%
Eye Inflammation: 1 person, 5.88%
Dry Mouth: 1 person, 5.88%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 5 people, 29.41%
Head Injury: 4 people, 23.53%
Diarrhea: 4 people, 23.53%
Pneumonia: 4 people, 23.53%
Headache (pain in head): 3 people, 17.65%
Anaemia (lack of blood): 3 people, 17.65%
Dizziness: 3 people, 17.65%
Nausea And Vomiting: 3 people, 17.65%
Back Pain: 3 people, 17.65%
Fall: 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weakness?

- Check whether Weakness is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Extranodal marginal zone b-cell lymphoma (malt type) (1,320 reports)
Weakness (586,877 reports)

All the drugs that are associated with Weakness:

Weakness (3,638 drugs)

All the conditions that are associated with Weakness:

Weakness (6,617 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weakness and Extranodal marginal zone b-cell lymphoma (malt type), and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.